Advertisement

Topics

Vedolizumab-treated CD Patients Undergoing Abdominal Surgery

08:00 EDT 17 Apr 2018 | Medscape

Biologic therapies are known to increase infection risk. How does vedolizumab impact the incidence of postoperative infectious complications among Crohn's disease patients?
Alimentary Pharmacology & Therapeutics

Original Article: Vedolizumab-treated CD Patients Undergoing Abdominal Surgery

NEXT ARTICLE

More From BioPortfolio on "Vedolizumab-treated CD Patients Undergoing Abdominal Surgery"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Crohn's Disease (CD)
Crohn’s disease (CD) is a long-term condition that causes inflammation of the lining of the digestive system.  Inflammation can affect any part of the digestive system, from the mouth to the back passage, but most commonly occurs in the last s...